Decipher Genomics Resource for Intelligent Discovery (GRID®)

G

GenomeDx Biosciences

Status

Invitation-only

Conditions

Bladder Cancer
Renal Cancer
Prostate Cancer

Treatments

Other: Decipher Cancer Classifier

Study type

Observational

Funder types

Industry

Identifiers

NCT02609269
GRD001

Details and patient eligibility

About

To prospectively evaluate the utility of genomic expression data as a tool to better characterize the tumors of individual patients, and to understand how genomic information from individual patients undergoing routine clinical testing can be used in population-level analysis to improve treatment and outcomes.

Full description

Observational study involving the release of tumor genome-wide expression data generated by the Decipher assay which will be linked to clinical treatment and outcome data for patients in whom Decipher clinical testing was performed. The GRID database population will be used to characterize the genomics of cancer and discover or validate gene expression signatures that may be useful for understanding of the biology of the disease and implementing precision medicine approaches for cancer patients.

Enrollment

1,000,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Subjects that have had a Decipher clinical test

Trial design

1,000,000 participants in 1 patient group

Decipher GRID Patients
Description:
Patients who have been tested with any of the Decipher clinical tests
Treatment:
Other: Decipher Cancer Classifier

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems